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Background: Previously, we identified a major quantitative trait locus (QTL) for host response to Porcine Respiratory
and Reproductive Syndrome virus (PRRSV) infection in high linkage disequilibrium (LD) with SNP rs80800372 on Sus
scrofa chromosome 4 (SSC4).
Results: Within this QTL, guanylate binding protein 5 (GBP5) was differentially expressed (DE) (p < 0.05) in blood
from AA versus AB rs80800372 genotyped pigs at 7,11, and 14 days post PRRSV infection. All variants within the
GBP5 transcript in LD with rs80800372 exhibited allele specific expression (ASE) in AB individuals (p < 0.0001). A
transcript re-assembly revealed three alternatively spliced transcripts for GBP5. An intronic SNP in GBP5, rs340943904,
introduces a splice acceptor site that inserts five nucleotides into the transcript. Individuals homozygous for the
unfavorable AA genotype predominantly produced this transcript, with a shifted reading frame and early stop
codon that truncates the 88 C-terminal amino acids of the protein. RNA-seq analysis confirmed this SNP was associated
with differential splicing by QTL genotype (p < 0.0001) and this was validated by quantitative capillary electrophoresis
(p < 0.0001). The wild-type transcript was expressed at a higher level in AB versus AA individuals, whereas the
five-nucleotide insertion transcript was the dominant form in AA individuals. Splicing and ASE results are consistent
with the observed dominant nature of the favorable QTL allele. The rs340943904 SNP was also 100 % concordant with
rs80800372 in a validation population that possessed an alternate form of the favorable B QTL haplotype.
Conclusions: GBP5 is known to play a role in inflammasome assembly during immune response. However, the role of
GBP5 host genetic variation in viral immunity is novel. These findings demonstrate that rs340943904 is a strong candidate
causal mutation for the SSC4 QTL that controls variation in host response to PRRSV.Background
Recently, Boddicker et al. [1, 2] identified a major QTL
on Sus scrofa chromosome 4 (SSC4) at 139136697–
140420778 that accounts for 15.7 % and 11.2 % of the
genetic variance for host response of young pigs to ex-
perimental PRRS virus infection, as measured by serum
viremia from 0 to 21 days post infection (dpi) and
weight gain to 42 dpi. In addition, a SNP (rs80800372)* Correspondence: jreecy@iastate.edu
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unless otherwise stated.was identified that appeared to be in complete LD with
the QTL. Biological candidate genes in the region that
have been previously studied include members of the
guanylate binding protein (GBP) family [3]. The five
members of the GBP family that are located in the QTL
region all represent potential candidate genes for the
QTL effect. The GBP proteins work together in an inter-
feron (IFN)-inducible complex to mediate a proinflamma-
tory immune response to stimuli such as the gram-negative
bacterial cell wall component lipopolysaccharide (LPS) [4].
The GBPs can stimulate caspase-11-dependent pyroptosis,
a specific form of apoptosis triggered by pathologicalThis is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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[5]. Both GBP2 and GBP3 have been associated with
the ability to control pathogen replication [3, 6] but
GBP3 is not assigned to the SSC4 QTL region. The
GBP5 protein has previously been shown to play a role
in immune response through mediation of inflammasome
assembly [7]. Thus, the SSC4 QTL region includes several
very good biological candidate genes, but because of high
LD in the region, further fine mapping of the QTL is
problematic.
The GBP5 protein is an important mediator of inflam-
matory immune response in mammals. Loss of GBP5
function in a knockout mouse model results in impaired
host defense and inflammatory response because GBP5
facilitates nucleotide binding and oligomerization,
leucine-rich repeat protein 3 (NLRP3) mediated inflam-
masome assembly [7]. Specifically, NLRP3 interacts
with tetrameric GBP5 to promote inflammasome assembly
with apoptosis-associated speck-like protein containing a
caspase activation and recruitment domain protein (ASC)
[7]. The 62 C-terminal amino acids of GBP5 are required
for tetramerization, and loss of tetrameric GBP5 abolished
NLRP3 inflammasome mediated ASC assembly [7]. Mice
lacking functional GBP5 had significantly reduced
neutrophil recruitment in response to peritonitis. Fur-
ther, these knockout mice also had increased bacterial
burdens, severely reduced CD11b + cells in mesenteric
lymph nodes and noticable weight loss in response to
L. monocytogenes infection [7]. In addition, one study
indicated that GBP5 expression was upregulated in
response to Epstein-Barr viral infection [8]. However,
the role and connection between GBP5 and viral
immune response has not been characterized.
The objective of this study was to use functional genom-
ics methods to identify the gene and mutation responsible
for the observed QTL on SSC4 for host response to PRRS
virus infection. We present evidence for a putative causal
mutation based on differential expression, allele specific
expression and differential splicing data that created an
illegitimate splice site in GBP5. Furthermore, we show
that the mutation is in 100 % linkage disequilibrium
(LD) with the previously reported SSC4 QTL in an
independent population.
Results
De novo transcript assembly to improve gene expression
quantification in the SSC4 region
Several genomic assembly issues were identified in the
SSC4 QTL region that made accurate quantification of
gene expression problematic. For example, the GBP5
transcript in the Sus scrofa 10.2 genome assembly
(Sscrofa build 10.2) was missing the C-terminal end of
GBP5 that contains a conserved CAAX box domain re-
quired for cellular localization. Using translated BLASTto compare RNA-seq reads to the human protein, exon
11 of GBP5 was identified approximately 200 kb 5′ of
the start site of GBP5 in Sscrofa build 10.2. In addition,
the predicted Ensembl gene ENSSSCG00000027014 was
noted to have nearly equal identity to fragments of
GBP2 and GBP4. We also identified several gaps in the
reference sequence within the QTL region in Sscrofa
build10.2 that were indicative of assembly problems. A
transcript reassembly was conducted, after which all
transcripts were compared to the pig and human
genomes to ensure the presence of the entire protein
coding sequence. For reference, the original order of
the genes from the Sscrofa build 10.2 is provided in
Additional file 1. Full-length transcripts were identified
for GBP4, GBP5, GBP6, GTF2B, CCBL2, and PKN2. The
GBP1 and GBP2 transcripts were assembled utilizing the
existing transcript information and the human tran-
scripts for these genes. The FASTA formatted sequence
of all cDNAs corresponding to the eight genes assem-
bled is provided in Additional file 2. We were unable to
identify fragments of the ENSSSCG00000027014 tran-
script from Sscrofa build 10.2 in our de -novo assembly.
Thus, this gene may be the product of a genome misas-
sembly, may not be expressed in whole blood, or may be
a non-functional gene duplication. The syntenic human
chromosomal block to the QTL region includes the
GBP3 gene but this gene was not found in the de novo
transcriptome assembly or by BLAST search of the hu-
man GBP3 protein against either the RNA-seq reads or
our de novo transcript assembly of this region. This gene
is also missing from Sscrofa build 10.2.
Read mapping statistics
Seventy sample sequences from 16 pigs and 5 time
points following experimental infection were retained
after quality control for identification of differentially
expressed (DE) genes (Additional file 3). The average
percentage of reads that uniquely mapped to the Sscrofa
build10.2 reference genome for these 70 samples was
82.1 %. Mapping percentages for individual samples are
provided in Additional file 4.
Identification of differentially expressed genes due to QTL
genotype
All eight gene transcripts from the SSC4 QTL region
were analyzed for differential expression, with a primary
focus on the effects of QTL genotype and genotype by
dpi. A total of three transcripts were DE due to genotype
across dpi, and 1, 3, and 1 transcripts were DE due to
genotype by day effects on 7, 10 and 14 dpi, respectively
(p < 0.05). No transcripts were DE at 0 and 4 dpi. Signifi-
cant transcript log2 fold changes are provided in Fig. 1a.
Genes that were DE due to genotype included GBP4,
GBP5, and GBP6; however, only GBP5 was DE across
Fig. 1 GBP5 is differentially expressed as a function of the PRRS host response QTL across timepoints. Guanylate binding protein 5 (GBP5) is
differentially expressed and exhibits allele specific expression (ASE) as a function of rs80800372 genotype at 0,4,7,11 and 14 days post infection
(dpi) with Porcine Reproductive and Respiratory Syndrome (PRRS) in PHGC trial 3 RNA-seq data. a Differences in the mean, model normalized
gene expression value and log2 fold change values for expression of GBP5 between the AB (blue) and AA (red) genotypes at the SSC4 QTL. *Indicates
false discovery rate < 0.05. b Schematic of the GBP5 transcript coding DNA sequence. Variants tested for ASE are shown in black text. The putative
causal mutation is shown in red text. The three protein domains shown were identified from the human GBP5 protein as annotated at Ensembl in
release 77. The box shown in orange corresponds to the p-loop containing nucleoside triphosphate hydrolase domain (7–279 amino acids (AA)). The
box shown in green corresponds to the GBP N and C terminal domains (18–280 AA and 282–577 AA, respectively). The box shown in red corresponds
to the CAAX box localization signal required for proper cellular localization of the GBP5 protein. ^The rs340943904 variant is not included in
the transcript and is shown here only to provide context since it is predicted to cause a shift in the transcript reading frame and an early stop
codon that truncates the 88 C-terminal AA of the protein. c Identification of ASE at 0,4,7,11 and 14 dpi for GBP5 for SNPs in phase with the B
rs80800372 allele. The 95 % confidence intervals for estimates of allele proportions are provided
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fold changes, p-values and false discovery rates (FDR)
for all genes in the SSC4 QTL region are presented in
Additional files 5, 6, and 7, respectively.
Allele Specific Expression (ASE) analysis identified higher
expression of GBP5 alleles in LD with the favorable QTL
allele
A total of 64 SNPs in the eight genes in the SSC4 QTL
region were in complete LD with the SSC4 QTL based
on concordance with rs80800372 genotype. These 64
SNPs were analyzed for ASE in animals that were het-
erozygous for rs80800372. All SNPs were filtered by
minimum read depth to avoid the analysis of false SNPs
due to sequencing errors. Of these 64 SNPs, 43 SNPs ex-
hibited ASE when averaged across dpi while FDR was
controlled at 5 %. The greatest number of SNPs identi-
fied that exhibited ASE per gene were in GBP2 (9 SNPs),
GBP4 (9 SNPs), GBP6 (7 SNPs), and GBP5 (6 SNPs).
The estimated probability of expression of the alternate
allele (palt) averaged across all dpi time points for these
SNPs in LD with the QTL are presented in Additional
file 8. However, GBP5 was the only gene with all SNPs
in LD that showed consistent main effects for ASE
across all SNPs tested, as presented in Fig. 1b and c.
Estimates of allelic proportions and p-values for these
ASE SNPs are presented for each dpi in Additional file 8.
A list of ASE results for additional SNPs that were
not in complete LD with rs80800372 is provided in
Additional file 9.
Identification of a putative causal mutation in GBP5 that
introduces an illegitimate splice acceptor site
Since GBP5 was DE between QTL genotypes at several
dpi, exhibited ASE, and was a strong biological candi-
date gene, we carefully examined the RNA sequence
data of this gene for variants. Interestingly, a T > G SNP
(sense strand) was identified in intron 9 of GBP5 that
appeared to introduce an additional splice acceptor site
five base pairs 5′ to the start of exon 10 in animals that
possessed the unfavorable A QTL allele. This splice ac-
ceptor SNP was previously assigned the NCBI dbSNP ID
rs340943904. The position of rs340943904 relative to
SNPs exhibiting ASE and the gene structure of GBP5 is
presented in Fig. 2a. The context of rs340943904 within
the GBP5 transcript is presented in Additional file 10.
Reads that mapped to GBP5 exon 9, intron 9 and exon
10 were evaluated for splicing consistent with multiple
alternatively spliced transcripts (Additional file 11).
Three alternate transcripts were identified, including the
wild-type transcript, a transcript with a five nucleotide
insertion 5′ to exon 10 (+5 bps transcript), and a tran-
script that retained intron 9 (retained intron transcript).
The rs340943904 G allele introduces a new splice acceptorsite, which causes five nucleotides to be inserted into the
GBP5 transcript. This five nucleotide insertion is expected
to shift the reading frame of GBP5, altering the first 10
amino acids encoded by exon 10 and introduces an early
stop codon that truncates the 88 C-terminal amino acids
of the protein, including the CAAX box. Transcripts that
contained the five-nucleotide insertion were identified
consistently in individuals with the AA QTL genotype, but
had a much lower frequency in individuals with the AB
QTL genotype. The transcript assembly confirmed the
presence of three GBP5 alternatively spliced transcripts
(wild-type, +5 bps and retained intron). The sequence of
the wild-type transcript is provided in Additional file 12.
Additional file 13 shows the predicted frameshift due to
the rs340943904 G allele at the protein level in AA and
AB QTL genotype individuals in comparison to the amino
acid sequence of GBP5 in human, cattle and mouse using
CLUSTALW [9]. The predicted effects of all other variants
detected in linkage disequilibrium or equilibrium with
rs80800372 are listed in Additional files 14 and 15,
respectively.
GBP5 exhibited differential splicing
To evaluate the relationship of altered GBP5 splicing
with the SSC4 QTL genotype, all RNA-seq reads that
discriminate the three alternatively spliced transcripts
were counted. Altered splicing was observed to segregate
consistently with the AA and AB rs80800372 genotypes.
A significantly lower number of wild-type splicing read
counts was present in AA compared to AB individuals,
after standardization of each alternate transcript as the
proportion of total reads produced per sample across all
three transcripts (p < 0.0001; Fig. 2b).
Independent validation of GBP5 differential splicing
The correspondence of differential splicing to the PRRS
QTL genotype was further validated in an analysis
across five dpi using AATI capillary electrophoresis
technology (Fig. 2c). The wild-type splicing transcript
was identified as over-expressed in RNA from whole
blood of AB vs. AA genotype animals (p < 0.01). In con-
trast, the +5 bp insertion allele was identified as over-
expressed in the AA vs. AB genotype animals (p < 0.05).
Abundance of the retained intron appeared to be similar
between genotypes. Removal or inclusion of the retained
intron in the statistical analysis did not change the
observed results.
RNA-seq validation using an independent population
Gene expression data from animals of a different genetic
background used in an independent validation study
were used to determine if GBP5 was DE between the
PRRS QTL genotypes. In the validation population
(PRRS Host Genome Consortium trial 5 (PHGC5)),
Fig. 2 Association and validation of guanylate binding protein 5 (GBP5) differential splicing with rs80800372 genotype. a Schematic of the
sequence level differences between the three alternate transcripts of GBP5, including the position of the putative causal variant (rs340943904,
bracketed). The schematic displays how the rs340943904 G allele creates a new splice acceptor site in intron 9 (underlined blue text) while the
T allele destroys the splice site. The wild-type splicing transcript includes only the sequence in black, while the +5bp insert transcript includes the
extra five nucleotides shown in blue. The retained intron transcript includes the entire 281 nucleotide intron. The rs340943904 G allele is in
perfect linkage disequilibrium (LD) with the unfavorable rs80800372 “A” allele while the rs340943904 T allele is in perfect LD with the favorable
rs80800372 “B” allele. b Differential splicing of GBP5 by rs80800372 genotype across all days post infection (dpi) time points. Splicing was
measured as the percentage of read counts from each alternate transcript standardized for all read counts from the PHGC trial 3 RNA-seq data.
This figure demonstrates that very little wild-type splicing transcript is produced by the AA (red) genotype compared to the AB (blue) rs80800372
genotype (p<0.0001; Bonferonni adjusted p<0.001). In contrast, considerably more of the alternate transcript (+5bps insertion) is produced in the
AA compared to the AB rs80800372 genotyped individuals. c Confirmation of GBP5 differential splicing due to rs80800372 genotype across all dpi
following infection using quantitative capillary electrophoresis. This analysis validates that very little or no wild-type splicing transcript is produced
by AA (red) vs. AB (blue) SSC4 rs80800372 genotyped individuals (p<0.01; Bonferonni adjusted p<0.05). Consistent with the RNA-seq results, more
of the alternate transcript with five extra nucleotides is quantified in blood RNA from AA vs. AB rs80800372 genotyped individuals. Expression
values are presented as transcript molarity
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lyzed in AA and AB rs80800372 genotyped pigs at the
same five time points (0,4,7,10 and 14 dpi; Fig. 3a) fol-
lowing experimental PRRS infection as in the present
study. GBP5 was DE for the main effect of genotypeand at four of the five dpi time points (FDR < 0.05;
Fig. 3a). Consistent with the first study, GBP5 differen-
tial splicing was associated with the rs340943904 SNP
genotype in the validation population (p < 0.0001;
Fig. 3c). Three SNPs within the GBP5 transcript were
Fig. 3 (See legend on next page.)
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Fig. 3 Validation of differential expression, splicing and allele specific expression of guanylate binding protein 5 (GBP5). GBP5 transcript levels and
allelic abundances were analyzed at 0,4,7,10 and 14 days post infection (dpi) with Porcine Reproductive and Respiratory Syndrome (PRRS) virus in
PHGC trial 5 RNA-seq data. a Validation of differential expression of GBP5 between the AB (blue) and AA (red) rs80800372 genotypes. *Indicates
false discovery rate < 0.05. b Validation of allele specific expression of GBP5 SNPs in phase with the B rs80800372 allele. c Validation of GBP5 differential
splicing due to rs80800372 genotype across dpi. Spliced reads uniquely mapping to the three alternate transcripts were analyzed as the percentage of
total reads from the RNA-seq data. Both the wild-type and five nucleotide insertion (+5 bps insertion) alleles were differentially spliced between the AA
(red bars) and AB (blue bars) rs80800372 genotypes (p < 0.0001; Bonferonni adjusted p < 0.001). There was a trend towards a small difference in the
quantity of the retained intron due to rs80800372 genotype (p = 0.06; Bonferonni adjusted p > 0.10). Alternate GBP5 transcripts are labeled on the X-axis
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(ss1414376807, rs333882393, rs323422273) did not
exhibit ASE. At least 3 of the 6 AB individuals with
RNA-seq data appear to be homozygous, and likely
uninformative. These results validate that GBP5 RNA
levels, splicing and ASE after PRRSV infection are dif-
ferent between PRRS SSC4 QTL genotypes and that
the rs340943904 SNP is the putative causative mutation
through alternative splicing.
Concordance of the GBP5 variant rs340943904 with
rs80800372 in an independent population
An allele specific SNP assay was developed to genotype
both the GBP5 rs340943904 and rs80800372 variants. A
total of 58 boars from an independent commercial York-
shire breeding population were genotyped to determine
the correspondence of the putative causal variant in
GBP5 with the rs80800372 SNP that tracks the PRRS
QTL. Importantly, despite the presence of two different B
rs80800372 QTL haplotypes [2], one in PHGC3 and a
second in the PHGC5 population, the rs340943904 SNP is
100 % concordant (data not shown).
Discussion
The goal of this study was to identify the gene and
causal variant responsible for the SSC4 QTL for PRRS
resistance. A secondary goal was to identify potential
molecular mechanisms for the QTL. The results of the
RNA-seq study provide multiple lines of evidence that
the rs340943904 splice acceptor mutation in GBP5 is a
strong candidate causal mutation for this QTL.
Porcine reproductive and respiratory syndrome (PRRS)
is the most costly infectious disease in the global pig in-
dustry [10] with an annual cost of $664 million to the
US industry alone [11]. PRRS is caused by infection with
an enveloped positive stranded RNA virus [12, 13]. Clin-
ical signs of PRRS include late-term reproductive failure
in sows and respiratory illness in growing pigs (reviewed
in [14]). PRRS virus is also a cofactor in other disease
syndromes, such as porcine respiratory disease complex
(PRDC) and porcine circovirus-associated disease
(PCVAD) [15, 16]. Vaccination for protection against
PRRSV infection has generally been unsuccessful, pri-
marily due to the high degree of antigenic and geneticdrift in viral structural and non-structural proteins and
the capacity of the virus to subvert early innate immune
responses [17]. Genetics of the host has been well docu-
mented as another factor associated with susceptibility
and response of the pig to PRRS [18–20]. The impact of
PRRS on swine health, well-being and severity of add-
itional pathogen infections when combined with PRRS
underscores the importance of host genetics and major
gene variation in porcine immune response.
Three genes were DE between the AA (unfavorable)
and AB (favorable) PRRS host response QTL genotypes
(FDR < 0.05). However, only GBP5 was identified as DE
across multiple time points post infection (FDR < 0.05)
and across all time points (FDR = 0.051). This result was
validated in an independent RNA-seq experiment from a
different pig population obtained through the PRRS host
genetics consortium (PHGC). Since this second study
was not designed specifically to identify differences in
gene expression due to the SSC4 QTL genotype, but also
focused on the effects of different host response pheno-
types, this result provides strong evidence that GBP5 is
DE due to QTL genotype. This result indicates that dif-
ferential expression of GBP5 is related to or mediates
the QTL effect on PRRS host response.
To provide additional evidence for differences in
expression, an ASE analysis of all SNPs in complete
LD with the PRRS host response QTL was conducted
to determine if evidence of allelic imbalance exists in
correspondence with the QTL genotype. GBP5 was
the only gene where all SNPs in LD with QTL exhib-
ited ASE. This result was validated in the independent
PHGC5 RNA-seq data set for three of the six SNPs.
The three SNPs that were not ASE appeared to be un-
informative based on the lack of expression of an al-
ternate allele in half of the AB animals in the PHGC5
dataset, which is supported by the multiple B QTL
haplotypes identified in this population [2]. There are
many potential reasons for statistical evidence of ASE,
including differences in regulatory factor binding, im-
printing, DNA methylation, RNA splicing, RNA stability,
RNA editing, and miRNA mediated silencing. Since all
SNPs in GBP5 exhibited ASE, we hypothesized that
ASE in GBP5 may occur due to differences in RNA
stability or splicing.
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indicated that GBP5 exhibited alternative splicing.
Concurrently, we identified the rs340943904 SNP in
GBP5, for which the allele that was in perfect LD with
the unfavorable A allele at the SSC4 QTL inserted five
nucleotides into the GBP5 transcript upstream of exon
10. This insertion is expected to result in an early stop
codon and thus a non-functional GBP5 protein. Since
this SNP was predicted to change the splicing of
GBP5, we used RNA-seq reads spanning the specific
splice junctions to quantify the three alternatively
spliced GBP5 transcripts across all time points. The
wild-type splicing transcript was expressed more in in-
dividuals with the AB QTL genotype (p < 0.001), while
the five nucleotide insertion transcript was more highly
expressed in AA individuals (p < 0.001). No difference in
expression was observed for the retained intron transcript
between genotypes. Splicing consistent with these results
was observed in a second population (Fig. 2c). We vali-
dated the differential splicing results using quantitative
capillary electrophoresis (p < 0.01). Interestingly, we
could not detect the wild-type splicing transcript in AA
individuals using this method. These results indicate
that individuals with the AA QTL genotype produce
almost no wild-type GBP5 transcript and an excess of
the transcript that is expected to produce a non-functional
protein. Thus, we predict that individuals with the AA
QTL genotype produce very little functional GBP5 pro-
tein. None of the other 63 SNPs in LD identified in the
QTL region (Additional files 12 and 13). The facts that AB
QTL genotyped individuals produce significantly more
wild-type splicing transcript than AA individuals, and that
AA individuals produce almost no wild-type splicing
GBP5, while producing large amounts of a non-functional
transcript, are consistent with the observed dominance of
the B QTL allele [21]. It is unclear whether the differential
expression of GBP5 completely depends on differential
splicing, since the rs340943904 SNP is in perfect LD with
the PRRS host response QTL. Thus, it is difficult to deter-
mine whether the genotype-specific differences in GBP5
expression are directly related to changes in splicing or
caused by other mechanisms involved in transcript stabil-
ity such as nonsense mediated decay.
To further validate the degree of concordance of the
rs340943904 SNP with the SSC4 PRRS host response
QTL, this SNP was genotyped along with the rs80800372
SNP in an independent set of pigs from a different
PHGC trial that showed the same effect of the SSC4
region on host response to PRRS. Despite the pres-
ence of a different B QTL haplotype, the rs340943904
SNP was 100 % concordant with the rs80800372 SNP
in 58 commercial Yorkshire boars. Since these boars
represent a different genetic background from the ones
used in this study, this further supports that rs340943904is the causal mutation for the SSC4 PRRS host response
QTL.
The GBP proteins are excellent candidates to play
important roles in host response to bacterial and viral
infections. Recent studies of the GBP5 knockout mouse
indicate that GBP5 functions in host defense, inflamma-
some assembly, and inflammatory response [7]. GBP5
serves as an important adaptor and mediator protein in
NLRP3 inflammasome activation. Furthermore, deletion
of the 67 C-terminal amino acids of GBP5 abolished the
NLRP3 mediated inflammasome assembly and down-
stream immune response. Protein modeling was used to
confirm that the structure of the C-terminus of GBP5
appears to be conserved across the human, mouse and
pig [22] (Additional file 16). The splice mutation de-
scribed in this study results in severely reduced expres-
sion of wild-type GBP5 and a frameshift that leads to an
early stop codon and truncation of the 88 C-terminal
amino acids. These results indicate that pigs with the
AA QTL genotype likely have very little to no GBP5
mediated NLRP3 inflammasome response to infection.
Relatively little is known about the role of GBP5 in hu-
man or animal immune responses to viruses. One study
indicates that GBP5 expression is upregulated during
Epstien-Barr viral infection [8]; however, the role of
GBP5 in viral immune response is unknown. The im-
plication that GBP5 plays a role in host genetic re-
sponse to PRRS may indicate additional biological roles
for GBP5 in host suppression of viral replication.
Therefore, this study may direct new avenues of re-
search into the role of GBP5 in viral immune response
and in identification of novel therapeutic targets.
Conclusions
In conclusion, we present multiple lines of evidence that
the introduction of a new splice acceptor site in GBP5 at
the rs340943904 SNP is a putative causal mutation for
the SSC4 host PRRS response QTL. First, RNA-seq ana-
lyses in two independent populations confirm that GBP5
was DE as a function of SSC4 QTL genotype. Second,
all GBP5 SNPs in perfect LD with the SSC4 QTL exhib-
ited ASE, with a shift towards higher expression of al-
leles that were in phase with the favorable B QTL allele.
Third, differential splicing of GBP5 was associated with
specific SSC4 QTL genotypes. Fourth, the rs340943904
SNP was validated to be in perfect LD with the SSC4
QTL in an independent genetic background. Fifth, the
rs340943904 SNP introduced five nucleotides into exon
10 of the GBP5 transcript, which is predicted to shift the
reading frame and result in an early stop codon that
truncates the 88 C-terminal amino acids. Finally, almost
no wild-type GBP5 transcript was produced in individuals
with the AA QTL genotype. Since GBP5 is known to play
a role in host immune response and inflammation based
Koltes et al. BMC Genomics  (2015) 16:412 Page 9 of 13on studies in the knockout mouse, it is a strong candidate
gene for the SSC4 PRRS host response QTL. For these
reasons, we believe that the rs340943904 GBP5 SNP is the
causal mutation for this economically important QTL.
Methods
Experimental design and population
Sixteen barrows from 8 litters, one AB and one AA individ-
ual at the rs80800372 SNP from each litter, were selected
from a population of 200 commercial crossbred piglets
that had been experimentally infected with PRRS isolate
NVSL97-7985 as part of the PRRS Host Genetics Consor-
tium (PHGC trial 3 described in Boddicker et al. [1]). No
BB animals were used in the RNA-seq analysis due to the
low frequency of this genotype and evidence that the effect
of the B allele on host response is dominant [21]. Animals
were between 18–28 days of age at day 0 of the trial. Whole
blood and serum samples from 0, 4, 7, 10, and 14 dpi were
obtained from each individual. Whole blood samples were
collected using the TempusTM Blood RNA Tubes (Life
Technologies, Carlsbad, CA, USA) to facilitate RNA isola-
tion and serum samples were used to quantify viral level
using a semi-quantitative TaqMan PCR assay [19].
Ethics statement
All animal experiments were approved by the Kansas
State University Institutional Animal Care and use com-
mittee under registration number 3000.
RNA-seq sample pre-processing
Total RNA was isolated from 77 available PHGC3 Tem-
pusTM preserved blood samples using the TempusTM
Spin RNA Isolation Kit (catalogue #: 4380204; Life
Technologies, Grand Island, NY, USA) according to the
manufacturer’s protocol as previously described [23]. A
ND-1000 spectrophotometer (Nano-Drop Technolo-
gies, Wilmington, DE, USA) was used to quantify RNA
concentrations. The globin transcripts (HBA and HBB)
were reduced using an RNase H based globin reduction
method [23] that used porcine specific oligonucleotides
modified from an Affymetrix GeneChip GR Protocol
for reduction of human globin mRNA. To determine
the quality of the RNA both prior to and following glo-
bin reduction, RNA samples were assayed for their 28S
to 18S rRNA ratio using an Agilent 2100 Bioanalyzer
(Agilent Technologies, Inc., Santa Clara, CA, USA).
RNA integrity numbers (RIN) were determined using
the Bioanalyzer both pre and post globin reduction.
Library preparation and RNA-sequencing details
Library construction was conducted at the Iowa State
University DNA facility with the TruSeqTM library kit
(Illumina, Inc., San Diego, USA) according to the manu-
facturer’s protocol. Sequencing was done on an IlluminaHiSeq machine using 100 cycles and the paired-end read
methodology to generate 100 base pair reads, as de-
scribed by the manufacturer (Illumina, Inc., San Diego,
USA). Samples from each pair of littermates were allo-
cated to one lane, for a total of 8 lanes, such that litter
effects were confounded with lane effects and, thus,
power to detect genotype effects was maximized. Initial
processing of reads from the HiSeq machine used the
Illumina CASAVA (v1.8) software.
Bioinformatics
Read quality assessment
All reads for all 77 samples were analyzed with the Sickle
software [24] to remove poor quality sequence and ensure
no adaptor remnants remained with any read. Each sample
was then checked with FASTQC software (available at:
http://www.bioinformatics.babraham.ac.uk/projects/fastqc/)
to determine if it had adequate read quality for downstream
analyses (i.e. reasonable read length, GC content, low per-
centage of repeated sequence). Seven of the 77 samples
were removed from all further analyses due to poor read
mapping (fewer than 1 million reads mapped to the refer-
ence genome), or inconsistent sequence-based genotype for
the rs80800372 SNP with the SNP chip based genotype for
that animal. A total of 70 samples were thus retained for
DE analysis (see Additional file 3).
De novo transcript creation
In order to create the transcripts for the SSC4 QTL re-
gion, several approaches were utilized. Reads from all
time points from one AB genotype animal were com-
bined and trimmed using Sickle [24] to reduce noise and
increase the quality of reads. Then Velvet [25] and Oases
[26] software programs were used to create a de novo
assembly of transcripts, which were compared back
against the existing transcript information for the refer-
ence genome assembly (Sscrofa10.2). Transcripts located
within the QTL region were identified within the de
novo assembly using the BLAST/ BLAT alignment tool
at Ensembl (http://uswest.ensembl.org/Sus_scrofa/blast-
view). All transcripts were translated and compared
against the orthologous human protein to validate the
accuracy of the transcripts. When full length transcripts
were not identified in the de novo transcript assembly,
the complete pig transcript was assembled using the ap-
propriate reads that created the full length protein that
exhibited high similarity to the corresponding human
orthologue based on the BLAST results.
RNA-seq read processing
To produce a common set of transcript coordinates for all
samples, sequence reads for each sample were mapped to
the Sscrofa 10.2 reference using Tophat/Bowtie2 [27, 28].
Alignment files from all samples were merged into a single
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a set of common transcript coordinates for the 70 samples.
For each sample, any reads that aligned to the HBB and
HBA reference sequences were removed before htseq
analysis [30], using the common transcript coordinates
to determine discrete counts for each transcript.
Variant identification
SNPs in the QTL region were used to perform allele-
specific expression analysis. Each BAM file produced by
Tophat was reformatted using Picard tools [31] and then
used to detect SNPs and small insertion and deletion
(INDEL) mutations using the Genome Analysis Tool Kit
[32] guided by the Sscrofa build 10.2 genome assembly.
To facilitate ASE analyses, the emit_all_bases of GATK
was used to capture the read counts at each base, regard-
less of the observation of an alternative allele. In addition,
the down sampling option was turned off to allow for all
read counts to be recorded for a SNP variant. These two
steps were important to evaluate SNP concordance with
genotype at the rs80800372 SNP. Two novel variants
identified in GBP5 in this study have been submitted to
NCBI dbSNP: ss1414376806 and ss1414376807. Additional
SNPs submitted to dbSNP are listed in Additional files 14
and 15.
RNA-seq 3′ read skewness calculation
Reads from the RNA-seq data were observed to have a 3′
read mapping bias, presumably due to globin depletion
and other systematic RNA processing factors [23]. The 3′
read skewness was calculated for each transcript as the
proportion of total reads with a midpoint right of the tran-
script midpoint. The read midpoint was determined using
the CIGAR string in each RNA-seq SAM file.
Differential gene expression analysis
Since the objective of this study was to identify potential
causal variants for the SSC4 QTL that impact host response
to PRRS, we focused on analysis of the differential expres-
sion only of genes within the SSC4 QTL region [1, 2].
Statistical analysis of RNA-seq gene expression
The trimmed mean of M values (TMM) normalization
procedure [33] from the edgeR package in R [34] was
used to normalize transcript counts based on the full set
of genome-wide counts. This procedure also adjusts for
the variation in library size seen across samples. Normal-
ized counts were then log2 transformed to obtain the
resulting scaled values used for analysis. A repeated
measures linear model was used that included the effects
of genotype (AA and AB), day (5 dpi), and genotype-by-
day interactions as class variables and the log normalized
transcript expression as the response. Additionally and
independently for each transcript, a class variable forfamily and covariates for pre- and post-globin-reduction
RIN, and 5′-3′ transcript read skewness were considered
to be included based on model selection using Aikake
information criterion (AIC) comparisons to select the
best model. This process was repeated for 4 error model
types: uncorrelated errors, autoregressive order 1(AR[1])
based on day, heterogeneous AR(1) (ARH[1]) based on
day, or an unstructured error model. The overall best fit-
ting model was then determined by AIC, separately for
each transcript. Contrasts were constructed to estimate
and test expression differences between genotypes
within and across days. The models were developed in R
using the gls function from the nlme package. Multiple
testing correction was conducted using the Benjamini &
Hochberg FDR [35].
Quality control and filtering of SNPs for the ASE analysis
The ASE analysis focused on SNP variants within the
QTL region. After variant calling, a shell script was
developed to extract the genotype and read counts for
each sample and each SNP for downstream analysis.
Within each individual, reference and alternate allele
counts for each SNP were obtained by summing across
that individual’s multiple time point samples. Using a
count cutoff of at least 2 times the number of time
points available for that individual, alleles at a SNP were
called as either present or absent in that individual for a
given SNP. SNPs were then filtered to compare the be-
havior of transcripts in LD (i.e. haplotypes) with either
the A or B QTL allele. For the initial ASE analyses, SNPs
were required to be in perfect LD with the rs80800372
SNP (i.e. the QTL). A total of 64 SNPs in LD with the
QTL were analyzed after applying these filters. In
addition, a second ASE analysis was conducted that in-
cluded all heterozygous SNPs regardless of LD status
with the QTL. These 67 SNPs were selected using the same
count cutoff; however, AA QTL genotyped individuals
were included.
ASE statistical analysis
Two separate analyses of ASE were conducted. The object-
ive of the first ASE analysis was to determine if the alleles
of SNPs in LD with the QTL had coordinated expression
patterns during PRRS viral infection. Only SNPs in AB
QTL genotyped individuals in LD with the QTL were used
in this analysis. A mixed nonlinear logistic regression model
was fit to the reference and alternate allele counts for each
SNP independently. Reference alleles were defined based
on the nucleotide present in the Sscrofa 10.2 genome build
whereas differing nucleotides were defined as alternate al-
leles. This model fit a random effect for each individual,
fixed effects for the day post infection and possibly included
RIN (both prior to and post globin depletion) numeric
values as continuous predictors based on model selection
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observing an alternate allele (palt), was obtained and a Wald
test was performed to determine whether palt differed from
0.5. Multiple testing correction was conducted using the
Benjamini & Hochberg FDR method [35]. Analyses were
performed using the lme4 package in R. The objective of
the second ASE analysis was to conducted an exhaustive
characterization of ASE in the QTL region. All SNPs
not in LD with rs80800372 were analyzed using the
same statistical approaches.
AATI differential splicing analysis
We used AATI capillary electrophoresis (Advanced Analyt-
ical, Ames, IA, USA) methodology to validate differential
splicing of the GBP5 transcripts. Two PCR primers were
designed to amplify a portion of the GBP5 transcript from
the 3′ end of exon 9 to the 5′ end of exon 10 using PHGC3
blood RNAs. The exon 9 primer consisted of the sequence:
5′- AGATCTGGC TCTCACACAAAGG -3′. The exon 10
primer consisted of the sequence 5′- GCCTCT GCTTGC
AAACGTG -3′. This AATI assay identified three alterna-
tively spliced transcripts: wild-type (i.e. capable of produ-
cing a functional protein), +5 bps (inserts five base pairs at
the start of exon 10), retained intron (transcript includes all
of intron 9 between exons 9 and 10). The AATI used in-
ternal standards to quantify all alternate transcript peaks at
the molarity level. Statistical analysis of the splicing data
was conducted using PROC Mixed of SAS. A model was fit
to determine if splicing of GBP5, measured as the molarity
of each alternate transcript, differed with QTL genotype.
The model included the fixed effects for genotype (AA or
AB), assay date (the AATI batch effect of samples run
together on the same day with 4 levels), alternate transcript
abundance (the GBP5 alternate-splicing transcripts: wild-
type, +5 bps, and retained intron), and a random effect of
animal to account for common effects of individuals across
days and shared effects on alternate transcripts.
Analysis of differential splicing of GBP5 from RNA-seq
data
A script was developed to count the number of reads
that uniquely represented the three splice variants of
GBP5 for all time points in the RNA-seq data. These
read counts were then analyzed using the same model as
described above for the AATI data to determine if differ-
ential splicing of the three alternatively spliced transcripts
was observed in the RNA-seq data, with the exception that
assay date was not necessary in the model.
Determination of concordance of the rs80800372 variant
with rs340943904 in GBP5 in an independent population
Allele specific PCR protocols were developed to genotype
both the rs80800372 and the GBP5 T>G SNP in intron 9
at position 139,413,978 bps (rs340943904) as described[36]. The rs80800372 SNP was genotyped using a common
forward primer: 5′-CCTTCTAGCTTCTCAGTGGA-3′
and specific primers for the “A” QTL allele: reverse primer:
5′-TTCGCTTCTCTAGCCCATTTATGT-3′ or the “B”
QTL allele: reverse primer: 5′-TTCGCTTCTCTAGCCC
ATTTATGC-3′. PCR was conducted with an annealing
temperature of 63.5 °C. The T >G SNP in intron 9 at pos-
ition 139,413,978 bps in GBP5 was genotyped using a com-
mon forward primer: 5′-AGCAAGAACAGCAAAGATG
T-3′ and specific primers for the G allele (corresponding to
the “A” QTL allele): reverse primer: 5′-TGCAAACGTG
CCTCTGAAC-3′ or the A allele (corresponding the “B”
QTL allele): reverse primer: 5′-TGCAAACGTGCCTCT
GAAA-3′. The PCR annealing temperature was also on
63.5 °C. A total of 58 commercial Yorkshire boars from an
independent, validation population were genotyped for
these two SNPs to determine the concordance of the GBP5
rs340943904 SNP with the rs80800372 SNP.Validation of RNA-seq results using an independent
population
An additional subset of animals from trial 5 of the
PHGC [2] was obtained for an independent RNA-seq
analysis. The RNA-seq data was created, processed,
checked for quality control, and mapped in similar man-
ner as described above and analyzed for differential
expression, splicing and ASE. A total of 15 AA and 5 AB
genotyped samples were analyzed for differential expres-
sion at 0, 4, 7, 11, and 14 dpi. All statistical analysis were
conducted with data from the same time points corre-
sponding to the initial PHGC trial 3 study using the
same methodology to contrast differences in gene
expression by QTL genotype. Read splicing as measured
in the RNA-seq data and ASE were also evaluated using
the same statistical models as described above for the
PHGC trial 3 data using 5 AB and 5 AA across dpi that
met the previously mentioned quality control standards.Availability of supporting data
The data sets supporting the results in this article are
available at NCBI. New variants identified for the ASE
analysis of GBP5 were deposited at dbSNP under acces-
sion numbers: ss1414376806 and ss1414376807. All add-
itional variants identified in this study are under the
accession numbers listed in Additional files 14 and 15.Additional files
Additional file 1: A schematic of all genes present in the Sus scrofa
chromosome 4 (SSC4) quantitative trait locus (QTL) region for PRRS
host response from the Sscrofa 10.2 genome build as presented at
Ensembl (acquired July 2, 2014 at: http://useast.ensembl.org).
Koltes et al. BMC Genomics  (2015) 16:412 Page 12 of 13Additional file 2: This is a file including the reassembled FASTA
sequence of all genes within the Sus scrofa chromosome 4 PRRS
host response QTL region at 139136697–140420778 Mbs.
Additional file 3: The number of individuals available at each time
point for RNAseq differential expression analysis following read
quality and count filtering (N = 70).
Additional file 4: Read mapping statistics for all samples used in
the RNAseq analysis. A total of 77 samples were initially processed, of
which, only 70 passed quality control based on read mapping and base
level quality scores.
Additional file 5: Model-estimated log2 fold changes for genes
analyzed for differential expression in the Sus scrofa chromosome
(SSC) 4 QTL region (139-140 Mb).
Additional file 6: P-values and Benjamini and Hochberg False
Discovery Rate (FDR) values associated with model-estimated fold
changes in Additional file 7.
Additional file 7: Normalized, model adjusted gene expression and
log2 fold changes for all genes tested for differential expression
(DE).
Additional file 8: Estimates of allelic proportions and p-values for
all SNPs in phase with the rs80800372 SNP B allele tested for allele
specific expression within the SSC4 QTL region in AB QTL genotyped
individuals. Results are presented based on averages across all 5 days
post infection (dpi) time points.
Additional file 9: Allele-specific expression analysis of SNPs not in
linkage disequlibrium with rs80800372. Results are presented based
on averages across all 5 days post infection (dpi) time points.
Additional file 10: Schematic of the guanylate binding protein
5( GBP5 )gene and alternate transcripts. A. A schematic of the GBP5
gene, including the context of all introns, start and stop codons, coding
SNPs, SNPs exhibiting allele specific expression and the putative causal
variant causing a new splice site in intron 9 (rs340943904). B. The three
alternate GBP5 transcripts, including the changes in exon 10 and
introduction of a premature stop codon that occurs in the translation of
two of the alternate transcripts. Intron lengths are based on those used
in the Sus scrofa build 10.2 genome assembly, with the length of intron
10 determined from sequencing a clone containing the 3′ end of the
gene.
Additional file 11: An image of RNAseq reads mapping to the Sus
scrofa 10.2 genome build in the integrated genome browser (1)
that shows the difference between the three GBP5 alternate
transcripts: wild-type, +5 bps and retained intron. This figure
presents an individual with the AB QTL genotype.
Additional file 12: The de novo FASTA nucleotide sequence of the
guanylate binding protein 5 transcript. Exons are shown in alternating
colors with the stop and start codons displayed in bold text. Exon
coordinates are as follows: Exon 1: 1–219, Exon 2: 220–428, Exon 3:
429–556, Exon 4: 557–666, Exon 5: 667–863, Exon 6: 864–1106, Exon 7:
1107–1387, Exon 8: 1388–1600, Exon 9: 1601–1703, Exon 10: 1704–1885,
Exon 11: 1886–2324.
Additional file 13: A CLUSTALW multiple protein alignment of the
AA and AB QTL genotype porcine amino acid sequence compared
to bovine, human and mouse GBP5 protein. Exons are color coded in
alternating blue and black colors. The portion of the protein frame-shifted in
the AA genotyped individuals is indicated by red text. The full-length amino
acid lengths of GBP5 are: pig AA QTL genotype: 498, pig AB QTL
(rs80800372) genotype: 586, bovine: 586, human: 586, mouse: 590.
The pig AA QTL genotype has 91 amino acids truncated compared
to the mouse (88 compared to all other species), which includes
portions of exons 10 and 11.
Additional file 14: Variants in linkage disequilibrium with
rs80800372 genotype identified in de novo transcriptome of the
Sus scrofa chromosome (SSC) 4 QTL Region. These variants were
discovered and filtered the same as those in Additional file 14: Table S1.
All nonsynonymous causing variants that are in LD with the rs80800372
genotype were determined to be minimally deleterious.Additional file 15: Variants not in linkage disequilibrium with
rs80800372 genotype identified in the de novo transcriptome of
the SSC4 QTL Region.
Additional file 16: The protein structure of guanylate binding
protein (GBP) 5 appears to be largely conserved between the
human, mouse and pig based on comparative protein structure
modeling. A. Human GBP5 modeled using the protein structure of human
GBP1 in the SWISS_MODEL protein homology modeler. The C-terminus (C)
and N-terminus (N) are marked for reference. B. Mouse GBP5 protein modeled
using the human GBP1 protein structure template. C. The Pig B form of the
GBP5 protein modeled using the human GBP1 protein structure template. D.
The Pig A form of the GBP5 protein modeled using the human GBP1 protein
structure template. Note, the A form of the protein is missing the 88 C-
terminal amino acids due to a frameshift caused by the insertion of five base
pairs just prior to the beginning of exon 10.
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